Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Doolan

Showing results (151-160 of 231) with videos related to

Pageof 24
Sort By:
Cell Host & Microbe|November 15, 2019
Protective Immunity against Severe Malaria in Children Is Associated with a Limited Repertoire of Antibodies to Conserved PfEMP1 VariantsSofonias K Tessema, Rie Nakajima, Algis Jasinskas, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 18, 2019
The Association between the Comprehensive Epstein-Barr Virus Serologic Profile and Endemic Burkitt LymphomaAnna E Coghill, Carla Proietti, Zhiwei Liu, et al.
BMJ Open|August 11, 2018
Protocol for the avatar acceptability study: a multiperspective cross-sectional study evaluating the acceptability of using patient-derived xenografts to guide personalised cancer care in Australia and New ZealandClaire E Wakefield, Emma L Doolan, Joanna E Fardell, et al.
Malaria Journal|June 9, 2009
Human T cell recognition of the blood stage antigen Plasmodium hypoxanthine guanine xanthine phosphoribosyl transferase (HGXPRT) in acute malariaTonia Woodberry, Alberto Pinzon-Charry, Kim A Piera, et al.
The Journal of Experimental Medicine|December 1, 1994
Dominant selection of an invariant T cell antigen receptor in response to persistent infection by Epstein-Barr virusV P Argaet, C W Schmidt, S R Burrows, et al.
Clinical and Vaccine Immunology : CVI|February 10, 2017
A Plasmodium vivax Plasmid DNA- and Adenovirus-Vectored Malaria Vaccine Encoding Blood-Stage Antigens AMA1 and MSP1<sub>42</sub> in a Prime/Boost Heterologous Immunization Regimen Partially Protects Aotus Monkeys against Blood-Stage ChallengeNicanor Obaldia, Michael G Stockelman, William Otero, et al.
Infection and Immunity|June 18, 2002
Persistence of protective immunity to malaria induced by DNA priming and poxvirus boosting: characterization of effector and memory CD8(+)-T-cell populationsMartha Sedegah, Gary T Brice, William O Rogers, et al.
Vaccine|June 1, 1997
Strategy for development of a pre-erythrocytic Plasmodium falciparum DNA vaccine for human useS L Hoffman, D L Doolan, M Sedegah, et al.
Ebiomedicine|November 3, 2018
The Avatar Acceptability Study: Survivor, Parent and Community Willingness to Use Patient-Derived Xenografts to Personalize Cancer CareC E Wakefield, E L Doolan, J E Fardell, et al.
Immunology and Cell Biology|August 1, 1997
Toward clinical trials of DNA vaccines against malariaS L Hoffman, D L Doolan, M Sedegah, et al.
Pageof 24

Showing results (151-160 of 231) with videos related to

Sort By:
Pageof 24
Cell Host & Microbe|November 15, 2019
Protective Immunity against Severe Malaria in Children Is Associated with a Limited Repertoire of Antibodies to Conserved PfEMP1 VariantsSofonias K Tessema, Rie Nakajima, Algis Jasinskas, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 18, 2019
The Association between the Comprehensive Epstein-Barr Virus Serologic Profile and Endemic Burkitt LymphomaAnna E Coghill, Carla Proietti, Zhiwei Liu, et al.
BMJ Open|August 11, 2018
Protocol for the avatar acceptability study: a multiperspective cross-sectional study evaluating the acceptability of using patient-derived xenografts to guide personalised cancer care in Australia and New ZealandClaire E Wakefield, Emma L Doolan, Joanna E Fardell, et al.
Malaria Journal|June 9, 2009
Human T cell recognition of the blood stage antigen Plasmodium hypoxanthine guanine xanthine phosphoribosyl transferase (HGXPRT) in acute malariaTonia Woodberry, Alberto Pinzon-Charry, Kim A Piera, et al.
The Journal of Experimental Medicine|December 1, 1994
Dominant selection of an invariant T cell antigen receptor in response to persistent infection by Epstein-Barr virusV P Argaet, C W Schmidt, S R Burrows, et al.
Clinical and Vaccine Immunology : CVI|February 10, 2017
A Plasmodium vivax Plasmid DNA- and Adenovirus-Vectored Malaria Vaccine Encoding Blood-Stage Antigens AMA1 and MSP1<sub>42</sub> in a Prime/Boost Heterologous Immunization Regimen Partially Protects Aotus Monkeys against Blood-Stage ChallengeNicanor Obaldia, Michael G Stockelman, William Otero, et al.
Infection and Immunity|June 18, 2002
Persistence of protective immunity to malaria induced by DNA priming and poxvirus boosting: characterization of effector and memory CD8(+)-T-cell populationsMartha Sedegah, Gary T Brice, William O Rogers, et al.
Vaccine|June 1, 1997
Strategy for development of a pre-erythrocytic Plasmodium falciparum DNA vaccine for human useS L Hoffman, D L Doolan, M Sedegah, et al.
Ebiomedicine|November 3, 2018
The Avatar Acceptability Study: Survivor, Parent and Community Willingness to Use Patient-Derived Xenografts to Personalize Cancer CareC E Wakefield, E L Doolan, J E Fardell, et al.
Immunology and Cell Biology|August 1, 1997
Toward clinical trials of DNA vaccines against malariaS L Hoffman, D L Doolan, M Sedegah, et al.
Pageof 24